![Carl Mats Wahlgren](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carl Mats Wahlgren
Keine laufenden Positionen mehr
Karriereverlauf von Carl Mats Wahlgren
Ehemalige bekannte Positionen von Carl Mats Wahlgren
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
World Health Organization
![]() World Health Organization SupranationalGovernment World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Hiv Research Trust | Direktor/Vorstandsmitglied | - | - |
MODUS THERAPEUTICS HOLDING AB | Direktor/Vorstandsmitglied | 01.01.2011 | - |
Gründer | 01.01.2011 | - | |
Modus Therapeutics AB
![]() Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Direktor/Vorstandsmitglied | 26.10.2004 | - |
Technik-/Wissenschafts-/F&E-Leiter | - | - | |
Gründer | 26.10.2004 | - | |
Karolinska Institutet | Corporate Officer/Principal | - | - |
Dilafor AB
![]() Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Gründer | 01.01.2003 | - |
Statistik
International
Schweden | 5 |
Schweiz | 2 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 4 |
Founder | 3 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Government | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MODUS THERAPEUTICS HOLDING AB | Health Technology |
Private Unternehmen | 4 |
---|---|
World Health Organization
![]() World Health Organization SupranationalGovernment World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland. | Government |
Dilafor AB
![]() Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Health Technology |
Modus Therapeutics AB
![]() Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Health Technology |
Hiv Research Trust |
- Börse
- Insiders
- Carl Mats Wahlgren
- Erfahrung